Sign in
4

Changes in Ownership

Coherus Oncology, Inc. Filed Acc 0000899243-16-019891

Options or other derivatives

  • Chief Scientific Officer acquired 69,236 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Herman Alan C. · Chief Scientific Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2016-05-11 Grant or award : show line 1 in the form Stock Option (Right to Buy) −69,236 69,236 D
Loading xslF345X03/doc4.xml…